ASBPW — Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: US
• Exchange: NASDAQ
• Employees: 2
• Website: https://aspirebiolabs.com

Latest SEC filings for ASBPW

• SCHEDULE 13G/A — 2026-08-14
• SCHEDULE 13G/A — 2026-08-07
• SCHEDULE 13G — 2026-05-15
• SCHEDULE 13G/A — 2026-05-13
• EFFECT — 2026-04-15
• S-1/A — 2026-04-10
• 10-K/A — 2026-04-08
• SCHEDULE 13G — 2026-02-12
• 8-K — 2026-02-12
• 8-K — 2026-01-15

Abrir análisis completo

Educational tool only — not investment advice.